Currently, there are 114.19M common shares owned by the public and among those 92.01M shares have been available to trade.
The company’s stock has a 5-day price change of 34.45% and 10.14% over the past three months. ABSI shares are trading -4.29% year to date (YTD), with the 12-month market performance up to 74.78% higher. It has a 12-month low price of $2.02 and touched a high of $6.72 over the same period. ABSI has an average intraday trading volume of 1.12 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 34.06%, 11.39%, and -4.77% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Absci Corp (NASDAQ: ABSI) shares accounts for 62.22% of the company’s 114.19M shares outstanding.
It has a market capitalization of $461.72M and a beta (3y monthly) value of 2.03. The earnings-per-share (ttm) stands at -$0.94. Price movements for the stock have been influenced by the stock’s volatility, which stands at 10.27% over the week and 9.21% over the month.
Earnings per share for the fiscal year are expected to increase by 30.21%, and 11.79% over the next financial year.
Looking at the support for the ABSI, a number of firms have released research notes about the stock. Guggenheim stated their Buy rating for the stock in a research note on October 02, 2024, with the firm’s price target at $10. Morgan Stanley coverage for the Absci Corp (ABSI) stock in a research note released on July 03, 2024 offered a Overweight rating with a price target of $7. Scotiabank was of a view on March 14, 2024 that the stock is Sector Outperform, while KeyBanc Capital Markets gave the stock Overweight rating on December 05, 2023, issuing a price target of $3. H.C. Wainwright on their part issued Buy rating on May 04, 2023.
